Jazz Pharmaceuticals (JAZZ) Depreciation and Depletion (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Depreciation and Depletion of $9.1 million for Q1 2026, down 12.5% year-over-year from $10.4 million in Q1 2025, and down 3.47% quarter-over-quarter from $9.4 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Depreciation and Depletion (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Depreciation and Depletion history runs 17 years deep, the most recent figure standing at $9.1 million for Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 12.5% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $40.3 million (up 13.62% YoY), while the FY2025 annual figure was $41.6 million, up 27.12% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $9.1 million, down from $9.4 million in the prior quarter.
- The five-year high for Depreciation and Depletion was $11.9 million in Q2 2025, with the low at $7.3 million in Q4 2022.
- The 5-year median for Depreciation and Depletion is $7.7 million (2022), against an average of $8.5 million.
- The sharpest annual moves came in 2022 and 2026: Depreciation and Depletion jumped 59.38% in 2022, then slipped 12.5% in 2026.
- Jazz Pharmaceuticals' Depreciation and Depletion stood at $7.3 million in 2022, then grew by 4.14% to $7.6 million in 2023, then increased by 24.4% to $9.5 million in 2024, then decreased by 0.91% to $9.4 million in 2025, then fell by 3.47% to $9.1 million in 2026.
- Business Quant data shows JAZZ's Depreciation and Depletion at $9.1 million in Q1 2026, $9.4 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 9.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.10 Mn |
| Jun 30, 2026 | 9.10 Mn |
| Mar 31, 2026 | 9.10 Mn |
| Mar 31, 2026 | 9.10 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Sep 30, 2025 | 9.88 Mn |
| Sep 30, 2025 | 9.88 Mn |
| Jun 30, 2025 | 11.93 Mn |
| Jun 30, 2025 | 11.93 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Dec 31, 2024 | 9.51 Mn |
| Dec 31, 2024 | 9.51 Mn |
| Sep 30, 2024 | 7.78 Mn |
| Sep 30, 2024 | 7.78 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Mar 31, 2024 | 7.65 Mn |
| Mar 31, 2024 | 7.65 Mn |